Triathlon Medical Venture Partners logo

Triathlon Medical Venture Partners

North America, Ohio, United States, Cincinnati

Description

Triathlon Medical Venture Partners, a Midwest-based venture capital firm, finances life sciences companies.

Investor Profile

Triathlon Medical Venture Partners has made 35 investments, with 0 in the past 12 months and 23% as lead.

Stage Focus

  • Series B (26%)
  • Series Unknown (20%)
  • Series C (20%)
  • Series A (17%)
  • Series E (6%)
  • Series D (6%)
  • Series H (3%)
  • Series G (3%)

Country Focus

  • United States (91%)
  • United Kingdom (6%)
  • Israel (3%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Therapeutics
  • Pharmaceutical
  • Manufacturing
  • Health Diagnostics
  • Product Design
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Triathlon Medical Venture Partners frequently co-invest with?

New Science Ventures
North America, Connecticut, United States, Greenwich
Co-Investments: 5
Blue Chip Venture Company
North America, Ohio, United States, Cincinnati
Co-Investments: 5
Athenian Venture Partners
North America, Florida, United States, Fort Lauderdale
Co-Investments: 5
Orchard Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 4
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 6
Domain Associates
North America, California, United States, San Diego
Co-Investments: 4
Satter Investment Management
North America, Illinois, United States, Chicago
Co-Investments: 4
Kearny Venture Partners
North America, California, United States, San Francisco
Co-Investments: 6
Venture Investors
North America, Wisconsin, United States, Madison
Co-Investments: 8
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 6

What are some of recent deals done by Triathlon Medical Venture Partners?

Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series UnknownMar 16, 2017
Amount Raised: $40,000,000
CoLucid Pharmaceuticals

Durham, North Carolina, United States

CoLucid Pharmaceuticals is a biotechnology company focusing on therapies for central nervous system disorders.

BiotechnologyMedical DevicePharmaceutical
Series CJan 13, 2015
Amount Raised: $37,100,000
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series CApr 23, 2014
Amount Raised: $22,000,000
Alluxa

Santa Rosa, California, United States

Alluxa is a manufacturer of optical filters and thin-film coatings in Santa Rosa, California.

Electrical DistributionLaserManufacturingNanotechnologyTelecommunications
Series UnknownApr 18, 2014
Amount Raised: $7,000,000
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series ANov 6, 2013
Amount Raised: $36,000,000
Akebia Therapeutics

Cambridge, Massachusetts, United States

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

BiotechnologyHealth CareTherapeutics
Series CJun 4, 2013
Amount Raised: $41,000,000
Tolera Therapeutics

Kalamazoo, Michigan, United States

Tolera Therapeutics is a spin-off of the Cleveland Clinic focused on bringing specific and safer therapies to treat various diseases.

BiotechnologyMedicalTherapeutics
Series BOct 16, 2012
Amount Raised: $5,500,000
Juventas Therapeutics

Cleveland, Ohio, United States

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

BiotechnologyHealth CareLife ScienceMedicalMedical DeviceTherapeutics
Series BJul 16, 2012
Amount Raised: $22,200,000
Mitralign

Tewksbury, Massachusetts, United States

Mitralign is focused on developing a catheter-based technology for the percutaneous treatments of functional mitral regurgitation.

Health CareMedicalMedical Device
Series DMay 16, 2012
Amount Raised: $35,000,000
CoLucid Pharmaceuticals

Durham, North Carolina, United States

CoLucid Pharmaceuticals is a biotechnology company focusing on therapies for central nervous system disorders.

BiotechnologyMedical DevicePharmaceutical
Series UnknownAug 30, 2011
Amount Raised: $7,500,000